LIMN
#4900
Liminatus Pharma, Inc. - Class A Common Stock
4.2 3 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-3.86%
Variazione Mensile
+3745.45%
Variazione di 6 mesi
+1592.00%
Variazione Annuale
+43.39%
Chiusura Precedente
4.4 0
Open
4.2 3
Minimo
4.2 3
Massimo
4.2 3
Volume
9
Financials
2026
Current report, 18 Aug 2026
Liminatus Pharma, Inc. current report, 18 August 2026
8-K
Current report, Q3 FY2026
Liminatus Pharma, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Liminatus Pharma, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Liminatus Pharma, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Liminatus Pharma, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Liminatus Pharma, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Liminatus Pharma, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Liminatus Pharma, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Liminatus Pharma, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Liminatus Pharma, Inc. quarterly report, Q1 FY2026
10-Q